175 related articles for article (PubMed ID: 32402703)
1. Developmental and epileptic encephalopathy due to SZT2 genomic variants: Emerging features of a syndromic condition.
Trivisano M; Rivera M; Terracciano A; Ciolfi A; Napolitano A; Pepi C; Calabrese C; Digilio MC; Tartaglia M; Curatolo P; Vigevano F; Specchio N
Epilepsy Behav; 2020 Jul; 108():107097. PubMed ID: 32402703
[TBL] [Abstract][Full Text] [Related]
2. Novel biallelic SZT2 mutations in 3 cases of early-onset epileptic encephalopathy.
Tsuchida N; Nakashima M; Miyauchi A; Yoshitomi S; Kimizu T; Ganesan V; Teik KW; Ch'ng GS; Kato M; Mizuguchi T; Takata A; Miyatake S; Miyake N; Osaka H; Yamagata T; Nakajima H; Saitsu H; Matsumoto N
Clin Genet; 2018 Feb; 93(2):266-274. PubMed ID: 28556953
[TBL] [Abstract][Full Text] [Related]
3. Biallelic SZT2 variants in a child with developmental and epileptic encephalopathy.
Tanaka R; Takahashi S; Kuroda M; Takeguchi R; Suzuki N; Makita Y; Narumi-Kishimoto Y; Kaname T
Epileptic Disord; 2020 Aug; 22(4):501-505. PubMed ID: 32723703
[TBL] [Abstract][Full Text] [Related]
4. Biallelic mutations in SZT2 cause a discernible clinical entity with epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum.
Nakamura Y; Togawa Y; Okuno Y; Muramatsu H; Nakabayashi K; Kuroki Y; Ieda D; Hori I; Negishi Y; Togawa T; Hattori A; Kojima S; Saitoh S
Brain Dev; 2018 Feb; 40(2):134-139. PubMed ID: 28893434
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotype and genetic characteristics of SZT2 related diseases: A case report and literature review.
Zhang X; Han Y; Yang L; Xu N; Zhu L; Qiu S; Li Y; Xu L; Yu X
Seizure; 2024 Jan; 114():111-120. PubMed ID: 38134649
[TBL] [Abstract][Full Text] [Related]
6. A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy.
Naseer MI; Alwasiyah MK; Abdulkareem AA; Bajammal RA; Trujillo C; Abu-Elmagd M; Jafri MA; Chaudhary AG; Al-Qahtani MH
Genes Genomics; 2018 Nov; 40(11):1149-1155. PubMed ID: 30315519
[TBL] [Abstract][Full Text] [Related]
7. Compound heterozygous SZT2 mutations in two siblings with early-onset epilepsy, intellectual disability and macrocephaly.
Domingues FS; König E; Schwienbacher C; Volpato CB; Picard A; Cantaloni C; Mascalzoni D; Lackner P; Heimbach A; Hoffmann P; Stanzial F; Hicks AA; Parmeggiani L; Benedicenti F; Pellegrin S; Casara G; Pramstaller PP
Seizure; 2019 Mar; 66():81-85. PubMed ID: 30818181
[TBL] [Abstract][Full Text] [Related]
8. A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant.
El Halabi T; Dirani M; Hotait M; Nasreddine W; Beydoun A
Epilepsia Open; 2021 Mar; 6(1):73-78. PubMed ID: 33681650
[TBL] [Abstract][Full Text] [Related]
9. Novel SZT2 mutations in three patients with developmental and epileptic encephalopathies.
Sun X; Zhong X; Li T
Mol Genet Genomic Med; 2019 Sep; 7(9):e926. PubMed ID: 31397114
[TBL] [Abstract][Full Text] [Related]
10. SZT2 mutation in a boy with intellectual disability, seizures and autistic features.
Kariminejad A; Yazdan H; Rahimian E; Kalhor Z; Fattahi Z; Zonooz MF; Najmabadi H; Ashrafi M
Eur J Med Genet; 2019 Sep; 62(9):103556. PubMed ID: 30359774
[TBL] [Abstract][Full Text] [Related]
11. Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum.
Basel-Vanagaite L; Hershkovitz T; Heyman E; Raspall-Chaure M; Kakar N; Smirin-Yosef P; Vila-Pueyo M; Kornreich L; Thiele H; Bode H; Lagovsky I; Dahary D; Haviv A; Hubshman MW; Pasmanik-Chor M; Nürnberg P; Gothelf D; Kubisch C; Shohat M; Macaya A; Borck G
Am J Hum Genet; 2013 Sep; 93(3):524-9. PubMed ID: 23932106
[TBL] [Abstract][Full Text] [Related]
12. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
[TBL] [Abstract][Full Text] [Related]
13. Insight into Genetic Mutations of SZT2: Is It a Syndrome?
Muthaffar OY; Jan MMS; Alyazidi AS; Alotibi TK; Alsulami EA
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760843
[TBL] [Abstract][Full Text] [Related]
14. Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants.
Venkatesan C; Angle B; Millichap JJ
Epileptic Disord; 2016 Jun; 18(2):195-200. PubMed ID: 27248490
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 functional assay reveals SZT2 loss-of-function variants and a founder in-frame deletion.
Calhoun JD; Aziz MC; Happ HC; Gunti J; Gleason C; Mohamed N; Zeng K; Hiller M; Bryant E; Mithal DS; Bellinski I; Kinsley L; Grimmel M; Schwaibold EMC; Smith-Hicks C; Chassevent A; Scala M; Accogli A; Torella A; Striano P; Capra V; Bird LM; Ben-Sahra I; Ekhilevich N; Hershkovitz T; Weiss K; Millichap J; Gerard EE; Carvill GL
Brain; 2022 Jun; 145(6):1939-1948. PubMed ID: 35773235
[TBL] [Abstract][Full Text] [Related]
16. An amino acid deletion inSZT2 in a family with non-syndromic intellectual disability.
Falcone M; Yariz KO; Ross DB; Foster J; Menendez I; Tekin M
PLoS One; 2013; 8(12):e82810. PubMed ID: 24324832
[TBL] [Abstract][Full Text] [Related]
17. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: A multicenter study.
Trivisano M; Pietrafusa N; Terracciano A; Marini C; Mei D; Darra F; Accorsi P; Battaglia D; Caffi L; Canevini MP; Cappelletti S; Cesaroni E; de Palma L; Costa P; Cusmai R; Giordano L; Ferrari A; Freri E; Fusco L; Granata T; Martino T; Mastrangelo M; Bova SM; Parmeggiani L; Ragona F; Sicca F; Striano P; Specchio LM; Tondo I; Zambrelli E; Zamponi N; Zanus C; Boniver C; Vecchi M; Avolio C; Dalla Bernardina B; Bertini E; Guerrini R; Vigevano F; Specchio N
Epilepsia; 2018 Dec; 59(12):2260-2271. PubMed ID: 30451291
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease.
Nakamura Y; Kato K; Tsuchida N; Matsumoto N; Takahashi Y; Saitoh S
PLoS One; 2019; 14(8):e0221482. PubMed ID: 31430354
[TBL] [Abstract][Full Text] [Related]
19. The Dysfunctional Gangway:
Cherian A; Divya KP; Pavuluri H; Thomas B
J Pediatr Neurosci; 2021; 16(4):289-292. PubMed ID: 36531768
[TBL] [Abstract][Full Text] [Related]
20. The SZT2 Interactome Unravels New Functions of the KICSTOR Complex.
Cattelani C; Lesiak D; Liebscher G; Singer II; Stasyk T; Wallnöfer MH; Heberle AM; Corti C; Hess MW; Pfaller K; Kwiatkowski M; Pramstaller PP; Hicks AA; Thedieck K; Müller T; Huber LA; Eca Guimaraes de Araujo M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
